Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7460fbf2ee11e2907adf25651c0aaab http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_617578a52a35d3dc96860992ace48fb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b1683a82729a57bb41396f738906f6e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-88 |
filingDate |
2007-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95dd4bf1053481f07a8e82a21fed61ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24b4c912317f0d25fe0f76df8fe3e726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b92ce8b97d1a42f7993a8bea12d20669 |
publicationDate |
2007-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007254022-A1 |
titleOfInvention |
Cationic liposome delivery of taxanes to angiogenic blood vessels |
abstract |
Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or cationic liposomes containing a substance which affects the targeted cells by inhibiting or promoting their growth. A site of angiogenesis can be precisely located by administering cationic liposomes containing a detectable label. The complexes may comprise nucleotide constructs which are comprised of promoters which are selectively and exclusively activated in the environment of an angiogenic endothelial cell. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005266067-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010303912-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010272822-A1 |
priorityDate |
1997-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |